These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 68814)

  • 41. M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium.
    Sternberg CN; Yagoda A; Scher HI; Whitmore WF; Herr HW; Morse MJ; Sogani PC; Watson RC; Hollander PS; Fair WR
    Prog Clin Biol Res; 1988; 260():481-5. PubMed ID: 3283768
    [No Abstract]   [Full Text] [Related]  

  • 42. A phase II trial of cyclophosphamide, doxorubicin, and cisplatin in advanced breast cancer.
    Kochupillai V; Gupta P; Misra A
    Am J Clin Oncol; 1992 Oct; 15(5):388-91. PubMed ID: 1524038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
    Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
    Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemotherapy of head and neck cancer: combination treatment with cyclophosphamide, adriamycin, methotrexate, and bleomycin.
    Wittes RE; Spiro RH; Shah J; Gerold FP; Koven B; Strong EW
    Med Pediatr Oncol; 1977; 3(3):301-9. PubMed ID: 85249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination chemotherapy for advanced bladder cancer.
    Hall RR; Evans RG; Pritchett CJ; Price DA
    Br J Urol; 1982 Feb; 54(1):16-9. PubMed ID: 6174167
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluation.
    Muggia FM; Perloff M; Chia GA; Reed LJ; Escher GC
    Cancer Chemother Rep; 1974; 58(6):919-26. PubMed ID: 4614899
    [No Abstract]   [Full Text] [Related]  

  • 47. Combination chemotherapy (CISCA) for advanced urinary tract carcinoma. A preliminary report.
    Sternberg JJ; Bracken RB; Handel PB; Johnson DE
    JAMA; 1977 Nov; 238(21):2282-7. PubMed ID: 578848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preliminary trials with a combination of adriamycin (NSC-123127) and bleomycin (NSC-125066) in adult malignancies.
    Tormey DC; Bergevin P; Blom J; Petty W
    Cancer Chemother Rep; 1973; 57(4):413-8. PubMed ID: 4128422
    [No Abstract]   [Full Text] [Related]  

  • 49. [Chemotherapy of the advanced cancer of the rectum].
    Navarro Izquierdo A; Zubiri L; Paracuellos S; Solsona F
    Rev Esp Enferm Apar Dig; 1977 Jan; 49(1):65-72. PubMed ID: 64994
    [No Abstract]   [Full Text] [Related]  

  • 50. The treatment of advanced carcinoma of the bladder with combination chemotherapy.
    McGeorge A; Hart AJ; Rundle JS; McVie JG; Calman KC
    Br J Urol; 1982 Aug; 54(4):366-8. PubMed ID: 7052188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin.
    Merrin C; Cartagena R; Wajsman Z; Baumgartner G; Murphy GP
    J Urol; 1975 Dec; 114(6):884-7. PubMed ID: 1195468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methotrexate (NSC-740) and bleomycin (NSC-125066) in the treatment of advanced epidermoid carcinoma of the uterine cervix.
    de Palo GM; Bajetta E; Luciani L; Musumeci R; Di Re F; Bonadonna G
    Cancer Chemother Rep; 1973; 57(4):429-35. PubMed ID: 4128423
    [No Abstract]   [Full Text] [Related]  

  • 53. Phase II trial of sequentially administered cisplatin, cyclophosphamide and doxorubicin for urothelial tract tumors.
    Schwartz S; Yagoda A; Natale RB; Watson RC; Whitmore WF; Lesser M
    J Urol; 1983 Oct; 130(4):681-4. PubMed ID: 6684180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy in the management of invasive bladder cancer. A review.
    Bush H; Thatcher N; Barnard R
    Cancer Chemother Pharmacol; 1979; 3(2):87-96. PubMed ID: 389480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A trial of bleomycin versus adriamycin in advanced carcinoma of the bladder.
    Turner AG; Durrant KR; Malpas JS
    Br J Urol; 1979 Apr; 51(2):121-4. PubMed ID: 88987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjuvant chemotherapy for bladder cancer with doxorubicin hydrochloride and cyclophosphamide: preliminary report.
    Merrin C; Beckley S
    J Urol; 1978 Jan; 119(1):62-3. PubMed ID: 621817
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single-drug chemotherapy of bladder cancer with adriamycin, VM-26 or bleomycin. A phase II multicentric, co-operative study.
    Eur Urol; 1976; 2(3):138-41. PubMed ID: 70352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Can we rely on lymphovascular invasion for determining the need for adjuvant chemotherapy in organ-confined bladder cancer?
    Gakis G; Stenzl A
    BJU Int; 2015 Jul; 116(1):3-4. PubMed ID: 26123071
    [No Abstract]   [Full Text] [Related]  

  • 59. Investigational chemotherapeutic agents in head and neck cancer.
    Rozencweig M; Von Hoff DD; Muggia FM
    Semin Oncol; 1977 Dec; 4(4):425-9. PubMed ID: 74096
    [No Abstract]   [Full Text] [Related]  

  • 60. The chemotherapy of bladder carcinoma: systemic therapy.
    Harker WG; Torti FM
    Recent Results Cancer Res; 1983; 85():37-49. PubMed ID: 6408717
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.